nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemcitabine—RRM1—adrenal gland cancer	0.374	0.904	CbGaD
Gemcitabine—pancreatic cancer—adrenal gland cancer	0.195	0.378	CtDrD
Gemcitabine—kidney cancer—adrenal gland cancer	0.163	0.316	CtDrD
Gemcitabine—lung cancer—adrenal gland cancer	0.157	0.305	CtDrD
Gemcitabine—ABCB1—adrenal gland cancer	0.0397	0.096	CbGaD
Gemcitabine—POLD1—gonad—adrenal gland cancer	0.00109	0.0449	CbGeAlD
Gemcitabine—POLD1—adrenal gland—adrenal gland cancer	0.000952	0.0391	CbGeAlD
Gemcitabine—SLC29A2—cardiac atrium—adrenal gland cancer	0.000915	0.0376	CbGeAlD
Gemcitabine—CMPK1—gonad—adrenal gland cancer	0.000872	0.0358	CbGeAlD
Gemcitabine—CMPK1—cardiac atrium—adrenal gland cancer	0.000871	0.0358	CbGeAlD
Gemcitabine—CDA—adrenal gland—adrenal gland cancer	0.000855	0.0351	CbGeAlD
Gemcitabine—CMPK1—pituitary gland—adrenal gland cancer	0.000851	0.0349	CbGeAlD
Gemcitabine—POLE—gonad—adrenal gland cancer	0.000817	0.0336	CbGeAlD
Gemcitabine—SLC29A2—adrenal gland—adrenal gland cancer	0.000799	0.0328	CbGeAlD
Gemcitabine—POLE—pituitary gland—adrenal gland cancer	0.000797	0.0327	CbGeAlD
Gemcitabine—CMPK1—adrenal gland—adrenal gland cancer	0.00076	0.0312	CbGeAlD
Gemcitabine—POLE—adrenal gland—adrenal gland cancer	0.000712	0.0292	CbGeAlD
Gemcitabine—POLA1—pituitary gland—adrenal gland cancer	0.000687	0.0282	CbGeAlD
Gemcitabine—RRM1—adrenal cortex—adrenal gland cancer	0.000675	0.0277	CbGeAlD
Gemcitabine—RRM2—gonad—adrenal gland cancer	0.000673	0.0276	CbGeAlD
Gemcitabine—RRM2—pituitary gland—adrenal gland cancer	0.000656	0.027	CbGeAlD
Gemcitabine—POLA1—adrenal gland—adrenal gland cancer	0.000614	0.0252	CbGeAlD
Gemcitabine—RRM2—adrenal gland—adrenal gland cancer	0.000586	0.0241	CbGeAlD
Gemcitabine—RRM1—gonad—adrenal gland cancer	0.000559	0.023	CbGeAlD
Gemcitabine—RRM1—cardiac atrium—adrenal gland cancer	0.000558	0.0229	CbGeAlD
Gemcitabine—SLC29A1—adrenal cortex—adrenal gland cancer	0.000549	0.0225	CbGeAlD
Gemcitabine—RRM1—pituitary gland—adrenal gland cancer	0.000545	0.0224	CbGeAlD
Gemcitabine—DCK—adrenal cortex—adrenal gland cancer	0.000524	0.0215	CbGeAlD
Gemcitabine—TYMS—gonad—adrenal gland cancer	0.000507	0.0208	CbGeAlD
Gemcitabine—ABCC10—adrenal cortex—adrenal gland cancer	0.000499	0.0205	CbGeAlD
Gemcitabine—RRM1—adrenal gland—adrenal gland cancer	0.000487	0.02	CbGeAlD
Gemcitabine—SLC29A1—gonad—adrenal gland cancer	0.000454	0.0187	CbGeAlD
Gemcitabine—SLC29A1—cardiac atrium—adrenal gland cancer	0.000454	0.0186	CbGeAlD
Gemcitabine—SLC29A1—pituitary gland—adrenal gland cancer	0.000443	0.0182	CbGeAlD
Gemcitabine—TYMS—adrenal gland—adrenal gland cancer	0.000442	0.0181	CbGeAlD
Gemcitabine—DCK—gonad—adrenal gland cancer	0.000434	0.0178	CbGeAlD
Gemcitabine—DCK—cardiac atrium—adrenal gland cancer	0.000434	0.0178	CbGeAlD
Gemcitabine—DCK—pituitary gland—adrenal gland cancer	0.000424	0.0174	CbGeAlD
Gemcitabine—ABCC10—gonad—adrenal gland cancer	0.000414	0.017	CbGeAlD
Gemcitabine—ABCC10—cardiac atrium—adrenal gland cancer	0.000413	0.017	CbGeAlD
Gemcitabine—ABCC10—pituitary gland—adrenal gland cancer	0.000404	0.0166	CbGeAlD
Gemcitabine—TYMS—E2F transcription factor network—RRM1—adrenal gland cancer	0.000398	0.00854	CbGpPWpGaD
Gemcitabine—RRM1—Retinoblastoma (RB) in Cancer—TOP2A—adrenal gland cancer	0.000396	0.00849	CbGpPWpGaD
Gemcitabine—SLC29A1—adrenal gland—adrenal gland cancer	0.000396	0.0163	CbGeAlD
Gemcitabine—DCK—adrenal gland—adrenal gland cancer	0.000378	0.0155	CbGeAlD
Gemcitabine—TYMS—Nucleotide metabolism—RRM1—adrenal gland cancer	0.000378	0.00809	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000368	0.00788	CbGpPWpGaD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—RRM1—adrenal gland cancer	0.000361	0.00774	CbGpPWpGaD
Gemcitabine—ABCC10—adrenal gland—adrenal gland cancer	0.000361	0.0148	CbGeAlD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—RRM1—adrenal gland cancer	0.000346	0.00742	CbGpPWpGaD
Gemcitabine—RRM2—E2F mediated regulation of DNA replication—RB1—adrenal gland cancer	0.000331	0.00708	CbGpPWpGaD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—TOP2A—adrenal gland cancer	0.000326	0.00699	CbGpPWpGaD
Gemcitabine—POLA1—Extension of Telomeres—TERT—adrenal gland cancer	0.000322	0.0069	CbGpPWpGaD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—TOP2A—adrenal gland cancer	0.000313	0.00671	CbGpPWpGaD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—TOP2A—adrenal gland cancer	0.000305	0.00654	CbGpPWpGaD
Gemcitabine—CDA—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.000259	0.00555	CbGpPWpGaD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—TOP2A—adrenal gland cancer	0.00023	0.00492	CbGpPWpGaD
Gemcitabine—POLA1—E2F mediated regulation of DNA replication—RB1—adrenal gland cancer	0.000226	0.00484	CbGpPWpGaD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—TOP2A—adrenal gland cancer	0.000223	0.00478	CbGpPWpGaD
Gemcitabine—POLE—Mitotic G1-G1/S phases—TOP2A—adrenal gland cancer	0.00022	0.00472	CbGpPWpGaD
Gemcitabine—TYMS—E2F mediated regulation of DNA replication—RB1—adrenal gland cancer	0.000217	0.00464	CbGpPWpGaD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—TOP2A—adrenal gland cancer	0.000214	0.00458	CbGpPWpGaD
Gemcitabine—RRM1—E2F transcription factor network—RB1—adrenal gland cancer	0.000213	0.00456	CbGpPWpGaD
Gemcitabine—POLD1—Telomere Maintenance—TERT—adrenal gland cancer	0.000212	0.00454	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000211	0.00453	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—SDHB—adrenal gland cancer	0.000211	0.00452	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000207	0.00444	CbGpPWpGaD
Gemcitabine—POLE—Telomere Maintenance—TERT—adrenal gland cancer	0.000205	0.00439	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000199	0.00425	CbGpPWpGaD
Gemcitabine—RRM1—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.000196	0.00421	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.000193	0.00413	CbGpPWpGaD
Gemcitabine—RRM1—E2F transcription factor network—CDKN2A—adrenal gland cancer	0.000187	0.004	CbGpPWpGaD
Gemcitabine—RRM1—Retinoblastoma (RB) in Cancer—RB1—adrenal gland cancer	0.000185	0.00396	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.000185	0.00395	CbGpPWpGaD
Gemcitabine—SLC29A1—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.00018	0.00385	CbGpPWpGaD
Gemcitabine—POLE—G1 to S cell cycle control—RB1—adrenal gland cancer	0.000178	0.00381	CbGpPWpGaD
Gemcitabine—POLD1—Chromosome Maintenance—TERT—adrenal gland cancer	0.000177	0.00379	CbGpPWpGaD
Gemcitabine—RRM2—E2F transcription factor network—RB1—adrenal gland cancer	0.000175	0.00375	CbGpPWpGaD
Gemcitabine—POLE—Chromosome Maintenance—TERT—adrenal gland cancer	0.000171	0.00366	CbGpPWpGaD
Gemcitabine—RRM2—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.000162	0.00346	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—TOP2A—adrenal gland cancer	0.000157	0.00337	CbGpPWpGaD
Gemcitabine—POLE—G1 to S cell cycle control—CDKN2A—adrenal gland cancer	0.000156	0.00335	CbGpPWpGaD
Gemcitabine—RRM2—E2F transcription factor network—CDKN2A—adrenal gland cancer	0.000154	0.0033	CbGpPWpGaD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—RB1—adrenal gland cancer	0.000152	0.00326	CbGpPWpGaD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—TOP2A—adrenal gland cancer	0.000151	0.00322	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.000148	0.00317	CbGpPWpGaD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—RB1—adrenal gland cancer	0.000146	0.00313	CbGpPWpGaD
Gemcitabine—POLA1—Telomere Maintenance—TERT—adrenal gland cancer	0.000146	0.00313	CbGpPWpGaD
Gemcitabine—ABCB1—adrenal cortex—adrenal gland cancer	0.000144	0.00592	CbGeAlD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—RB1—adrenal gland cancer	0.000142	0.00305	CbGpPWpGaD
Gemcitabine—POLD1—Synthesis of DNA—RB1—adrenal gland cancer	0.00014	0.003	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—RRM1—adrenal gland cancer	0.000136	0.00291	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—SDHD—adrenal gland cancer	0.000136	0.00291	CbGpPWpGaD
Gemcitabine—POLE—Synthesis of DNA—RB1—adrenal gland cancer	0.000135	0.00289	CbGpPWpGaD
Gemcitabine—POLD1—DNA Replication—RB1—adrenal gland cancer	0.000131	0.00281	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—SDHB—adrenal gland cancer	0.00013	0.00279	CbGpPWpGaD
Gemcitabine—RRM2—G1/S Transition—RB1—adrenal gland cancer	0.000127	0.00272	CbGpPWpGaD
Gemcitabine—POLE—DNA Replication—RB1—adrenal gland cancer	0.000127	0.00271	CbGpPWpGaD
Gemcitabine—POLE—G1/S Transition—RB1—adrenal gland cancer	0.000122	0.00261	CbGpPWpGaD
Gemcitabine—POLA1—Chromosome Maintenance—TERT—adrenal gland cancer	0.000122	0.00261	CbGpPWpGaD
Gemcitabine—POLA1—E2F transcription factor network—RB1—adrenal gland cancer	0.00012	0.00257	CbGpPWpGaD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	0.00012	0.00256	CbGpPWpGaD
Gemcitabine—ABCB1—gonad—adrenal gland cancer	0.000119	0.0049	CbGeAlD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000119	0.00255	CbGpPWpGaD
Gemcitabine—ABCB1—pituitary gland—adrenal gland cancer	0.000117	0.00479	CbGeAlD
Gemcitabine—TYMS—E2F transcription factor network—RB1—adrenal gland cancer	0.000115	0.00246	CbGpPWpGaD
Gemcitabine—POLD1—S Phase—RB1—adrenal gland cancer	0.000115	0.00246	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000114	0.00244	CbGpPWpGaD
Gemcitabine—POLE—S Phase—RB1—adrenal gland cancer	0.000111	0.00237	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.00011	0.00236	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—TOP2A—adrenal gland cancer	0.000109	0.00235	CbGpPWpGaD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—RB1—adrenal gland cancer	0.000107	0.00229	CbGpPWpGaD
Gemcitabine—TYMS—Fluoropyrimidine Activity—TP53—adrenal gland cancer	0.000106	0.00227	CbGpPWpGaD
Gemcitabine—POLA1—E2F transcription factor network—CDKN2A—adrenal gland cancer	0.000105	0.00226	CbGpPWpGaD
Gemcitabine—ABCB1—adrenal gland—adrenal gland cancer	0.000104	0.00427	CbGeAlD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—RB1—adrenal gland cancer	0.000104	0.00223	CbGpPWpGaD
Gemcitabine—POLE—Mitotic G1-G1/S phases—RB1—adrenal gland cancer	0.000103	0.0022	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—MED12—adrenal gland cancer	0.000101	0.00217	CbGpPWpGaD
Gemcitabine—TYMS—E2F transcription factor network—CDKN2A—adrenal gland cancer	0.000101	0.00216	CbGpPWpGaD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—RB1—adrenal gland cancer	9.97e-05	0.00214	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—SDHB—adrenal gland cancer	9.87e-05	0.00211	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	9.75e-05	0.00209	CbGpPWpGaD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	9.69e-05	0.00208	CbGpPWpGaD
Gemcitabine—POLA1—Synthesis of DNA—RB1—adrenal gland cancer	9.62e-05	0.00206	CbGpPWpGaD
Gemcitabine—SLC28A1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	9.51e-05	0.00204	CbGpPWpGaD
Gemcitabine—RRM2—Mitotic G1-G1/S phases—CDKN2A—adrenal gland cancer	9.41e-05	0.00202	CbGpPWpGaD
Gemcitabine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PRKACA—adrenal gland cancer	9.2e-05	0.00197	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	9.06e-05	0.00194	CbGpPWpGaD
Gemcitabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—adrenal gland cancer	9.04e-05	0.00194	CbGpPWpGaD
Gemcitabine—POLE—Mitotic G1-G1/S phases—CDKN2A—adrenal gland cancer	9.04e-05	0.00194	CbGpPWpGaD
Gemcitabine—POLA1—DNA Replication—RB1—adrenal gland cancer	9.02e-05	0.00193	CbGpPWpGaD
Gemcitabine—POLE—G1 to S cell cycle control—TP53—adrenal gland cancer	8.7e-05	0.00186	CbGpPWpGaD
Gemcitabine—POLA1—G1/S Transition—RB1—adrenal gland cancer	8.69e-05	0.00186	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	8.52e-05	0.00183	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—TOP2A—adrenal gland cancer	8.42e-05	0.0018	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—SDHD—adrenal gland cancer	8.39e-05	0.0018	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—RRM1—adrenal gland cancer	8.39e-05	0.0018	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—TOP2A—adrenal gland cancer	8.37e-05	0.00179	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	8.33e-05	0.00179	CbGpPWpGaD
Gemcitabine—TYMS—G1/S Transition—RB1—adrenal gland cancer	8.33e-05	0.00178	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—SDHB—adrenal gland cancer	8.13e-05	0.00174	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	8.1e-05	0.00173	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—TOP2A—adrenal gland cancer	8.09e-05	0.00173	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—SDHB—adrenal gland cancer	8.08e-05	0.00173	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	7.98e-05	0.00171	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	7.9e-05	0.00169	CbGpPWpGaD
Gemcitabine—POLA1—S Phase—RB1—adrenal gland cancer	7.89e-05	0.00169	CbGpPWpGaD
Gemcitabine—SLC29A2—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	7.75e-05	0.00166	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—SDHB—adrenal gland cancer	7.6e-05	0.00163	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TOP2A—adrenal gland cancer	7.53e-05	0.00161	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TOP2A—adrenal gland cancer	7.49e-05	0.0016	CbGpPWpGaD
Gemcitabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—adrenal gland cancer	7.44e-05	0.0016	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	7.42e-05	0.00159	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PRKACA—adrenal gland cancer	7.39e-05	0.00158	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	7.37e-05	0.00158	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	7.34e-05	0.00157	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—RB1—adrenal gland cancer	7.32e-05	0.00157	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	7.25e-05	0.00155	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TOP2A—adrenal gland cancer	7.23e-05	0.00155	CbGpPWpGaD
Gemcitabine—SLC28A3—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	7.21e-05	0.00154	CbGpPWpGaD
Gemcitabine—POLE—Retinoblastoma (RB) in Cancer—TP53—adrenal gland cancer	7.15e-05	0.00153	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	7.12e-05	0.00153	CbGpPWpGaD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—RB1—adrenal gland cancer	7.02e-05	0.0015	CbGpPWpGaD
Gemcitabine—DCK—Retinoblastoma (RB) in Cancer—TP53—adrenal gland cancer	6.96e-05	0.00149	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	6.9e-05	0.00148	CbGpPWpGaD
Gemcitabine—ABCC10—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	6.78e-05	0.00145	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	6.76e-05	0.00145	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—PRKACA—adrenal gland cancer	6.63e-05	0.00142	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—PRKACA—adrenal gland cancer	6.59e-05	0.00141	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—adrenal gland cancer	6.44e-05	0.00138	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—PRKACA—adrenal gland cancer	6.37e-05	0.00136	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—SDHD—adrenal gland cancer	6.36e-05	0.00136	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—MED12—adrenal gland cancer	6.26e-05	0.00134	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	6.2e-05	0.00133	CbGpPWpGaD
Gemcitabine—TYMS—Mitotic G1-G1/S phases—CDKN2A—adrenal gland cancer	6.17e-05	0.00132	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	6.13e-05	0.00131	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—GNAS—adrenal gland cancer	5.99e-05	0.00128	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	5.94e-05	0.00127	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—ABCB1—adrenal gland cancer	5.88e-05	0.00126	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—TOP2A—adrenal gland cancer	5.76e-05	0.00123	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	5.74e-05	0.00123	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	5.69e-05	0.00122	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—TOP2A—adrenal gland cancer	5.52e-05	0.00118	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	5.48e-05	0.00117	CbGpPWpGaD
Gemcitabine—SLC29A1—Transmembrane transport of small molecules—ABCB1—adrenal gland cancer	5.37e-05	0.00115	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—SDHB—adrenal gland cancer	5.33e-05	0.00114	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—SDHD—adrenal gland cancer	5.24e-05	0.00112	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—RRM1—adrenal gland cancer	5.24e-05	0.00112	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—SDHD—adrenal gland cancer	5.21e-05	0.00112	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—RRM1—adrenal gland cancer	5.21e-05	0.00112	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TOP2A—adrenal gland cancer	5.15e-05	0.0011	CbGpPWpGaD
Gemcitabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—adrenal gland cancer	5.09e-05	0.00109	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	5.07e-05	0.00109	CbGpPWpGaD
Gemcitabine—POLE—Mitotic M-M/G1 phases—RB1—adrenal gland cancer	5.04e-05	0.00108	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TOP2A—adrenal gland cancer	4.94e-05	0.00106	CbGpPWpGaD
Gemcitabine—ABCB1—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	4.93e-05	0.00106	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—SDHD—adrenal gland cancer	4.89e-05	0.00105	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—RRM1—adrenal gland cancer	4.89e-05	0.00105	CbGpPWpGaD
Gemcitabine—TYMS—Retinoblastoma (RB) in Cancer—TP53—adrenal gland cancer	4.88e-05	0.00105	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—PRKACA—adrenal gland cancer	4.86e-05	0.00104	CbGpPWpGaD
Gemcitabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	4.82e-05	0.00103	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—MED12—adrenal gland cancer	4.74e-05	0.00102	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PRKACA—adrenal gland cancer	4.56e-05	0.000978	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	4.56e-05	0.000977	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—PRKACA—adrenal gland cancer	4.54e-05	0.000972	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TERT—adrenal gland cancer	4.51e-05	0.000967	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TERT—adrenal gland cancer	4.48e-05	0.000961	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	4.37e-05	0.000936	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—PRKACA—adrenal gland cancer	4.35e-05	0.000931	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TERT—adrenal gland cancer	4.33e-05	0.000928	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	4.08e-05	0.000874	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—POMC—adrenal gland cancer	4.03e-05	0.000864	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—RB1—adrenal gland cancer	3.93e-05	0.000841	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	3.91e-05	0.000838	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—MED12—adrenal gland cancer	3.91e-05	0.000837	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—RB1—adrenal gland cancer	3.9e-05	0.000836	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—MED12—adrenal gland cancer	3.88e-05	0.000832	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—RB1—adrenal gland cancer	3.77e-05	0.000808	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—GNAS—adrenal gland cancer	3.7e-05	0.000793	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—MED12—adrenal gland cancer	3.65e-05	0.000782	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—ABCB1—adrenal gland cancer	3.63e-05	0.000778	CbGpPWpGaD
Gemcitabine—POLA1—Mitotic M-M/G1 phases—RB1—adrenal gland cancer	3.59e-05	0.000769	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	3.52e-05	0.000754	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—RB1—adrenal gland cancer	3.51e-05	0.000752	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—RB1—adrenal gland cancer	3.49e-05	0.000748	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PRKACA—adrenal gland cancer	3.46e-05	0.000741	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	3.45e-05	0.00074	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—RRM1—adrenal gland cancer	3.43e-05	0.000735	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—SDHD—adrenal gland cancer	3.43e-05	0.000735	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	3.43e-05	0.000735	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—RB1—adrenal gland cancer	3.37e-05	0.000722	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	3.31e-05	0.00071	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	3.23e-05	0.000693	CbGpPWpGaD
Gemcitabine—CMPK1—Metabolism—PTGS2—adrenal gland cancer	3.22e-05	0.000689	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	3.1e-05	0.000664	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—CDKN2A—adrenal gland cancer	3.09e-05	0.000661	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TERT—adrenal gland cancer	3.09e-05	0.000661	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—CDKN2A—adrenal gland cancer	3.07e-05	0.000657	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—CDKN2A—adrenal gland cancer	2.96e-05	0.000635	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TERT—adrenal gland cancer	2.96e-05	0.000633	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PRKACA—adrenal gland cancer	2.85e-05	0.00061	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PRKACA—adrenal gland cancer	2.83e-05	0.000607	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—GNAS—adrenal gland cancer	2.8e-05	0.000601	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—ABCB1—adrenal gland cancer	2.75e-05	0.000589	CbGpPWpGaD
Gemcitabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	2.71e-05	0.000582	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—RB1—adrenal gland cancer	2.69e-05	0.000576	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PRKACA—adrenal gland cancer	2.66e-05	0.00057	CbGpPWpGaD
Gemcitabine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	2.6e-05	0.000557	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—RB1—adrenal gland cancer	2.57e-05	0.000551	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—MED12—adrenal gland cancer	2.56e-05	0.000548	CbGpPWpGaD
Gemcitabine—TYMS—Circadian rythm related genes—TP53—adrenal gland cancer	2.5e-05	0.000535	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—POMC—adrenal gland cancer	2.49e-05	0.000534	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—RB1—adrenal gland cancer	2.4e-05	0.000515	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	2.36e-05	0.000506	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—GNAS—adrenal gland cancer	2.31e-05	0.000495	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—RB1—adrenal gland cancer	2.3e-05	0.000493	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—GNAS—adrenal gland cancer	2.29e-05	0.000492	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—ABCB1—adrenal gland cancer	2.27e-05	0.000485	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle, Mitotic—CDKN2A—adrenal gland cancer	2.26e-05	0.000485	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—ABCB1—adrenal gland cancer	2.25e-05	0.000482	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—GNAS—adrenal gland cancer	2.16e-05	0.000462	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—ABCB1—adrenal gland cancer	2.12e-05	0.000454	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—CDKN2A—adrenal gland cancer	2.11e-05	0.000452	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—CDKN2A—adrenal gland cancer	2.02e-05	0.000433	CbGpPWpGaD
Gemcitabine—CDA—Metabolism—PTGS2—adrenal gland cancer	1.99e-05	0.000426	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—POMC—adrenal gland cancer	1.89e-05	0.000404	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PRKACA—adrenal gland cancer	1.87e-05	0.0004	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	1.83e-05	0.000393	CbGpPWpGaD
Gemcitabine—RRM2—Cell Cycle—TP53—adrenal gland cancer	1.72e-05	0.000368	CbGpPWpGaD
Gemcitabine—POLD1—Cell Cycle—TP53—adrenal gland cancer	1.71e-05	0.000366	CbGpPWpGaD
Gemcitabine—POLE—Cell Cycle—TP53—adrenal gland cancer	1.65e-05	0.000353	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SDHB—adrenal gland cancer	1.64e-05	0.000352	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—POMC—adrenal gland cancer	1.55e-05	0.000333	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—POMC—adrenal gland cancer	1.55e-05	0.000331	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—GNAS—adrenal gland cancer	1.51e-05	0.000324	CbGpPWpGaD
Gemcitabine—RRM1—Metabolism—PTGS2—adrenal gland cancer	1.51e-05	0.000323	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—ABCB1—adrenal gland cancer	1.48e-05	0.000318	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—POMC—adrenal gland cancer	1.45e-05	0.000311	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	1.35e-05	0.000289	CbGpPWpGaD
Gemcitabine—RRM2—Metabolism—PTGS2—adrenal gland cancer	1.24e-05	0.000266	CbGpPWpGaD
Gemcitabine—POLD1—Metabolism—PTGS2—adrenal gland cancer	1.23e-05	0.000264	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	1.23e-05	0.000263	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	1.21e-05	0.000258	CbGpPWpGaD
Gemcitabine—POLA1—Cell Cycle—TP53—adrenal gland cancer	1.18e-05	0.000252	CbGpPWpGaD
Gemcitabine—DCK—Metabolism—PTGS2—adrenal gland cancer	1.16e-05	0.000248	CbGpPWpGaD
Gemcitabine—TYMS—Cell Cycle—TP53—adrenal gland cancer	1.13e-05	0.000241	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—RRM1—adrenal gland cancer	1.06e-05	0.000227	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—SDHD—adrenal gland cancer	1.06e-05	0.000227	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—POMC—adrenal gland cancer	1.02e-05	0.000218	CbGpPWpGaD
Gemcitabine—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	9.97e-06	0.000214	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	9.56e-06	0.000205	CbGpPWpGaD
Gemcitabine—TYMS—Metabolism—PTGS2—adrenal gland cancer	8.13e-06	0.000174	CbGpPWpGaD
Gemcitabine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	8.02e-06	0.000172	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—MED12—adrenal gland cancer	7.9e-06	0.000169	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PRKACA—adrenal gland cancer	5.76e-06	0.000123	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—GNAS—adrenal gland cancer	4.67e-06	0.0001	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—POMC—adrenal gland cancer	3.14e-06	6.73e-05	CbGpPWpGaD
Gemcitabine—ABCB1—Metabolism—PTGS2—adrenal gland cancer	2.51e-06	5.37e-05	CbGpPWpGaD
